West Pharmaceutical Services Inc (WST)
316.59
-4.29
(-1.34%)
USD |
NYSE |
Nov 22, 16:00
316.53
-0.06
(-0.02%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Operations (Quarterly): 180.10M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 180.10M |
| June 30, 2024 | 165.00M |
| March 31, 2024 | 118.20M |
| December 31, 2023 | 239.10M |
| September 30, 2023 | 230.10M |
| June 30, 2023 | 169.20M |
| March 31, 2023 | 138.10M |
| December 31, 2022 | 230.80M |
| September 30, 2022 | 168.90M |
| June 30, 2022 | 173.10M |
| March 31, 2022 | 151.20M |
| December 31, 2021 | 160.80M |
| September 30, 2021 | 190.10M |
| June 30, 2021 | 144.40M |
| March 31, 2021 | 88.70M |
| December 31, 2020 | 148.70M |
| September 30, 2020 | 118.60M |
| June 30, 2020 | 148.10M |
| March 31, 2020 | 57.10M |
| December 31, 2019 | 106.40M |
| September 30, 2019 | 108.10M |
| June 30, 2019 | 105.10M |
| March 31, 2019 | 47.60M |
| December 31, 2018 | 73.20M |
| September 30, 2018 | 88.40M |
| Date | Value |
|---|---|
| June 30, 2018 | 82.00M |
| March 31, 2018 | 45.00M |
| December 31, 2017 | 81.50M |
| September 30, 2017 | 75.80M |
| June 30, 2017 | 85.30M |
| March 31, 2017 | 20.70M |
| December 31, 2016 | 71.80M |
| September 30, 2016 | 68.40M |
| June 30, 2016 | 76.20M |
| March 31, 2016 | 3.00M |
| December 31, 2015 | 68.00M |
| September 30, 2015 | 68.80M |
| June 30, 2015 | 77.50M |
| March 31, 2015 | -1.90M |
| December 31, 2014 | 46.00M |
| September 30, 2014 | 63.90M |
| June 30, 2014 | 64.20M |
| March 31, 2014 | 8.80M |
| December 31, 2013 | 68.80M |
| September 30, 2013 | 53.30M |
| June 30, 2013 | 79.50M |
| March 31, 2013 | 18.90M |
| December 31, 2012 | 69.80M |
| September 30, 2012 | 51.60M |
| June 30, 2012 | 52.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
57.10M
Minimum
Mar 2020
239.10M
Maximum
Dec 2023
156.34M
Average
156.00M
Median
Cash from Operations (Quarterly) Benchmarks
| Repligen Corp | 49.32M |
| Perspective Therapeutics Inc | 3.366M |
| Retractable Technologies Inc | -5.727M |
| Xtant Medical Holdings Inc | -1.718M |
| Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -82.10M |
| Cash from Financing (Quarterly) | -64.40M |
| Free Cash Flow | 321.60M |
| Free Cash Flow Per Share (Quarterly) | 1.346 |
| Free Cash Flow to Equity (Quarterly) | 102.00M |
| Free Cash Flow to Firm (Quarterly) | 98.80M |
| Free Cash Flow Yield | 1.37% |